TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MLTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
MLTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX

Rosen Law Firm is pursuing a securities class action lawsuit against MoonLake Immunotherapeutics, alleging false and misleading statements about their Nanobody technology and its clinical benefits during the period of March 10, 2024 to September 29, 2025.

Insights
MLTX   negative

The lawsuit alleges the company made false statements about its technology's clinical efficacy, suggesting potential misrepresentation of scientific claims and potential investor harm